Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe
ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in the Netherlands
The present report is concerned with the emerging infection of tick-borne encephalitis in the Netherlands — the two first endemic cases occurring in July 2016 — in the larger context of a widespread and increasing incidence of lyme borreliosis.
Conducting in-action and after-action reviews of the public health response to COVID-19
This document aims to support the implementation of after-action reviews (AARs) and in-action reviews (IARs) focused on the public health response to COVID-19.
Considerations relating to social distancing measures in response to COVID-19 – second update
This document aims to support public health preparedness planning and response activities based upon social distancing measures aimed at minimising the spread of COVID-19. Available in 26 languages.
Synergies in community and institutional public health emergency preparedness for tick-borne diseases in Spain
The present report is concerned with the events in Spain surrounding two cases of infection with Crimean-Congo Haemorrhagic Fever (CCHF) virus that emerged in the Autonomous Community of Castilla y León in August 2016.
COVID-19 clusters and outbreaks in occupational settings in the EU/EEA and the UK
The aim of this document is to describe COVID-19 clusters and outbreaks in the EU/EEA and the UK linked to occupational settings, including healthcare and non-healthcare settings, and to identify possible factors contributing to transmission in these settings.
Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK
This document provides principles of surveillance, infection prevention and control (IPC) and management of COVID-19 infection in prisons in European Union (EU) and European Economic Area (EEA) countries and the United Kingdom (UK).
Shiga toxin/verotoxin-producing Escherichia coli in humans, food and animals in the EU/EEA, with special reference to the German outbreak strain STEC O104
This joint report, produced by the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA), aims to give a short summary of reported Shiga toxin/verotoxin-producing Escherichia coli (STEC/VTEC) prevalence and incidence in humans, food and animals.
Novel coronavirus (SARS-CoV-2) - Discharge criteria for confirmed COVID-19 cases
This document suggests criteria to be considered when deciding whether a confirmed COVID-19 case can be safely (i.e. without being infectious) discharged from hospital or released from home isolation.
Baseline projections of COVID-19 in the EU/EEA and the UK: update
This report provides updated 30-day projections, together with the inherent model assumptions and uncertainties. Both the model projections and the data to which the model is calibrated should be interpreted with caution given the differences between national surveillance systems, case definitions and testing policies. Comparisons between countries based on the data and forecasts presented in this paper should only be made with extreme caution and should take these differences into account. Nonetheless, the projections presented here illustrate potential future trends in COVID-19 transmission in EU/EEA countries and the UK.